Rutin
- Generic Name
- Rutin
- Drug Type
- Small Molecule
- Chemical Formula
- C27H30O16
- CAS Number
- 153-18-4
- Unique Ingredient Identifier
- 5G06TVY3R7
- Background
A flavonol glycoside found in many plants, including buckwheat; tobacco; forsythia; hydrangea; viola, etc. It has been used therapeutically to decrease capillary fragility.
- Indication
用于脆性增加的毛细血管出血症，也用于高血压脑病、脑出血、视网膜出血、出血性紫癜、急性出血性肾炎、再发性鼻出血、创伤性肺出血、产后出血等的辅助治疗。
- Associated Conditions
- Anemia, General Surgery, Pregnancy
- Associated Therapies
- Vitamin supplementation
Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
Phase 1
Recruiting
- Conditions
- Muscle Invasive Bladder Cancer
- Interventions
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Target Recruit Count
- 10
- Registration Number
- NCT06916494
- Locations
- 🇨🇳
First Affiliated Hospital of Chongqing Medical University, ChongQing, Chongqing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath